Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lymphoma × Radiation × Clear all

Phase

Status

Completed 4 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Glioblastoma 9 Breast Neoplasms 9 Rectal Neoplasms 8 Lung Neoplasms 7 Head and Neck Neoplasms 7 Neoplasm Metastasis 6 Squamous Cell Carcinoma of Head and Neck 5 Brain Neoplasms 5 Sarcoma 4 Prostatic Neoplasms 4 Neoplasms 4 Leukemia 4 Gliosarcoma 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Myeloid, Acute 3 Carcinoma, Squamous Cell 3 Carcinoma, Merkel Cell 3 Adenocarcinoma Of Esophagus 3 Xerostomia 2 Waldenstrom Macroglobulinemia 2 Uterine Cervical Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Mucositis 2 Melanoma 2 Lymphoma, Non-Hodgkin 2

Interventions

Rituximab 54 Cyclophosphamide 46 fludarabine phosphate 21 fludarabine 20 Filgrastim 19 Methotrexate 17 Vincristine 16 Radiotherapy 16 Melphalan 16 Etoposide 16 Doxorubicin 15 Cytarabine 13 Whole-Body Irradiation 12 Tacrolimus 12 Prednisone 12 Mycophenolic Acid 12 Gemcitabine 12 Cyclosporine 12 Antilymphocyte Serum 12 Peripheral Blood Stem Cell Transplantation 11 Lenalidomide 11 Busulfan 9 Granulocyte Colony-Stimulating Factor 8 Dexamethasone 8 Cord Blood Stem Cell Transplantation 8 Bortezomib 8 sargramostim 7 Vorinostat 7 Methylprednisolone 7 Alemtuzumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01321008 2015-02-05

Stage I/II Nasal NK Cell Lymphoma

M.D. Anderson Cancer Center

Phase 1/2 Terminated

1 enrolled 3 charts

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡